Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Feb;67(784):195–197. doi: 10.1136/pgmj.67.784.195

Sjögren-like pluriglandular exocrine insufficiency after drug-induced toxic epidermal necrolysis.

J Sabán 1, J R Pais 1, J L Rodríguez 1, D Boixeda 1
PMCID: PMC2398994  PMID: 2041854

Abstract

We present the case of a patient that progressively developed xerophthalmia, xerostomia, cutaneous xerosis and exocrine pancreatic insufficiency 3 months after metamizole-induced toxic epidermal necrolysis. Though the association of Sjögren's syndrome and exocrine pancreatic impairment is well established, the Sjögren-like syndrome after drug-induced toxic epidermal necrolysis in association with such a wide exocrine glandular insufficiency has not been previously described, to our knowledge.

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arellano F., Soto J., Antepara I., Terrones J., Candina R., Pérez I., De Cos M. A. Epidermolisis necrótica por metamizol. Rev Clin Esp. 1990 Apr;186(6):305–307. [PubMed] [Google Scholar]
  2. Billingham R. E., Streilein J. W. Toxic epidermal necrolysis and homologous disease in hamsters. Arch Dermatol. 1968 Nov;98(5):528–539. [PubMed] [Google Scholar]
  3. Coll J., Navarro S., Tomas R., Elena M., Martinez E. Exocrine pancreatic function in Sjögren's syndrome. Arch Intern Med. 1989 Apr;149(4):848–852. [PubMed] [Google Scholar]
  4. Goldstein S. M., Wintroub B. W., Elias P. M., Wuepper K. D. Toxic epidermal necrolysis. Unmuddying the waters. Arch Dermatol. 1987 Sep;123(9):1153–1156. [PubMed] [Google Scholar]
  5. Gratwohl A. A., Gratwhol A. A., Moutsopoulos H. M., Chused T. M., Akizuki M., Wolf R. O., Sweet J. B., Deisseroth A. B. Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med. 1977 Dec;87(6):703–706. doi: 10.7326/0003-4819-87-6-703. [DOI] [PubMed] [Google Scholar]
  6. Guillaume J. C., Roujeau J. C., Revuz J., Penso D., Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol. 1987 Sep;123(9):1166–1170. [PubMed] [Google Scholar]
  7. Merot Y., Gravallese E., Guillén F. J., Murphy G. F. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case. Arch Dermatol. 1986 Apr;122(4):455–458. [PubMed] [Google Scholar]
  8. Peck G. L., Herzig G. P., Elias P. M. Toxic epidermal necrolysis in a patient with graft-vs-host reaction. Arch Dermatol. 1972 Apr;105(4):561–569. [PubMed] [Google Scholar]
  9. Revuz J., Penso D., Roujeau J. C., Guillaume J. C., Payne C. R., Wechsler J., Touraine R. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987 Sep;123(9):1160–1165. doi: 10.1001/archderm.123.9.1160. [DOI] [PubMed] [Google Scholar]
  10. Roman O., Nica E., Popescu L. Consideraţii asupra unui caz de sindrom Lyell. Rev Pediatr Obstet Ginecol Pediatr. 1986 Jul-Sep;35(3):261–266. [PubMed] [Google Scholar]
  11. Roujeau J. C., Huynh T. N., Bracq C., Guillaume J. C., Revuz J., Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 1987 Sep;123(9):1171–1173. [PubMed] [Google Scholar]
  12. Roujeau J. C., Moritz S., Guillaume J. C., Bombal C., Revuz J., Weil B., Touraine R. Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis. Arch Dermatol Res. 1985;277(1):24–27. doi: 10.1007/BF00406477. [DOI] [PubMed] [Google Scholar]
  13. Roujeau J. C., Phlippoteau C., Koso M., Wechsler J., Andre C., Binaghi M., Revuz J., Touraine R. Sjögren-like syndrome after drug-induced toxic epidermal necrolysis. Lancet. 1985 Mar 16;1(8429):609–611. doi: 10.1016/s0140-6736(85)92146-4. [DOI] [PubMed] [Google Scholar]
  14. Stein K. M., Schlappner O. L., Heaton C. L., Decherd J. W. Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis. Br J Dermatol. 1972 Mar;86(3):246–252. doi: 10.1111/j.1365-2133.1972.tb02224.x. [DOI] [PubMed] [Google Scholar]
  15. Westly E. D., Wechsler H. L. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch Dermatol. 1984 Jun;120(6):721–726. doi: 10.1001/archderm.120.6.721. [DOI] [PubMed] [Google Scholar]
  16. Whaley K., Goudie R. B., Williamson J., Nuki G., Dick W. C., Buchanan W. W. Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet. 1970 Apr 25;1(7652):861–863. doi: 10.1016/s0140-6736(70)91690-9. [DOI] [PubMed] [Google Scholar]
  17. Wick M. R., Moore S. B., Gastineau D. A., Hoagland H. C. Immunologic, clinical, and pathologic aspects of human graft-versus-host disease. Mayo Clin Proc. 1983 Sep;58(9):603–612. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES